Daniel T. Monaghan - Publications

University of Nebraska Medical Center, Omaha, NE, United States 
Neuroscience Biology, Molecular Biology, Pharmacology

89 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Sapkota K, Mao Z, Synowicki P, Lieber D, Liu M, Ikezu T, Gautam V, Monaghan DT. GluN2D NMDAR subunit contribution to the stimulation of brain activity and gamma oscillations by ketamine; implications for schizophrenia. The Journal of Pharmacology and Experimental Therapeutics. PMID 26675679 DOI: 10.1124/Jpet.115.230391  0.76
2015 Chopra DA, Monaghan DT, Dravid SM. Bidirectional Effect of Pregnenolone Sulfate on GluN1/GluN2A N-Methyl-D-Aspartate Receptor Gating Depending on Extracellular Calcium and Intracellular Milieu. Molecular Pharmacology. 88: 650-9. PMID 26162866 DOI: 10.1124/Mol.115.100396  0.76
2015 Irvine MW, Fang G, Eaves R, Mayo-Martin MB, Burnell ES, Costa BM, Culley GR, Volianskis A, Collingridge GL, Monaghan DT, Jane DE. Synthesis of a series of novel 3,9-disubstituted phenanthrenes as analogues of known N-methyl-D-aspartate receptor allosteric modulators Synthesis (Germany). 47: 1593-1610. DOI: 10.1055/s-0034-1380114  0.76
2013 Gautam V, Trinidad JC, Rimerman RA, Costa BM, Burlingame AL, Monaghan DT. Nedd4 is a specific E3 ubiquitin ligase for the NMDA receptor subunit GluN2D. Neuropharmacology. 74: 96-107. PMID 23639431 DOI: 10.1016/J.Neuropharm.2013.04.035  0.76
2013 Volianskis A, Bannister N, Collett VJ, Irvine MW, Monaghan DT, Fitzjohn SM, Jensen MS, Jane DE, Collingridge GL. Different NMDA receptor subtypes mediate induction of long-term potentiation and two forms of short-term potentiation at CA1 synapses in rat hippocampus in vitro. The Journal of Physiology. 591: 955-72. PMID 23230236 DOI: 10.1113/Jphysiol.2012.247296  0.76
2013 Collingridge GL, Volianskis A, Bannister N, France G, Hanna L, Mercier M, Tidball P, Fang G, Irvine MW, Costa BM, Monaghan DT, Bortolotto ZA, Molnár E, Lodge D, Jane DE. The NMDA receptor as a target for cognitive enhancement. Neuropharmacology. 64: 13-26. PMID 22796429 DOI: 10.1016/J.Neuropharm.2012.06.051  0.76
2012 Monaghan DT, Irvine MW, Costa BM, Fang G, Jane DE. Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators. Neurochemistry International. 61: 581-92. PMID 22269804 DOI: 10.1016/J.Neuint.2012.01.004  0.76
2012 Irvine MW, Costa BM, Volianskis A, Fang G, Ceolin L, Collingridge GL, Monaghan DT, Jane DE. Coumarin-3-carboxylic acid derivatives as potentiators and inhibitors of recombinant and native N-methyl-D-aspartate receptors. Neurochemistry International. 61: 593-600. PMID 22265875 DOI: 10.1016/J.Neuint.2011.12.020  0.76
2012 Costa BM, Irvine MW, Fang G, Eaves RJ, Mayo-Martin MB, Laube B, Jane DE, Monaghan DT. Structure-activity relationships for allosteric NMDA receptor inhibitors based on 2-naphthoic acid. Neuropharmacology. 62: 1730-6. PMID 22155206 DOI: 10.1016/J.Neuropharm.2011.11.019  0.76
2012 Irvine MW, Costa BM, Dlaboga D, Culley GR, Hulse R, Scholefield CL, Atlason P, Fang G, Eaves R, Morley R, Mayo-Martin MB, Amici M, Bortolotto ZA, Donaldson L, Collingridge GL, ... ... Monaghan DT, et al. Piperazine-2,3-dicarboxylic acid derivatives as dual antagonists of NMDA and GluK1-containing kainate receptors. Journal of Medicinal Chemistry. 55: 327-41. PMID 22111545 DOI: 10.1021/Jm201230Z  0.76
2012 Monaghan DT, Buller AL. Anatomical, pharmacological, and molecular diversity of native NMDA receptor subtypes The Nmda Receptor. DOI: 10.1093/acprof:oso/9780192625021.003.0006  0.76
2011 Jullienne A, Montagne A, Orset C, Lesept F, Jane DE, Monaghan DT, Maubert E, Vivien D, Ali C. Selective inhibition of GluN2D-containing N-methyl-D-aspartate receptors prevents tissue plasminogen activator-promoted neurotoxicity both in vitro and in vivo. Molecular Neurodegeneration. 6: 68. PMID 21975018 DOI: 10.1186/1750-1326-6-68  0.76
2010 Costa BM, Irvine MW, Fang G, Eaves RJ, Mayo-Martin MB, Skifter DA, Jane DE, Monaghan DT. A novel family of negative and positive allosteric modulators of NMDA receptors. The Journal of Pharmacology and Experimental Therapeutics. 335: 614-21. PMID 20858708 DOI: 10.1124/Jpet.110.174144  0.76
2010 Suárez F, Zhao Q, Monaghan DT, Jane DE, Jones S, Gibb AJ. Functional heterogeneity of NMDA receptors in rat substantia nigra pars compacta and reticulata neurones. The European Journal of Neuroscience. 32: 359-67. PMID 20618827 DOI: 10.1111/J.1460-9568.2010.07298.X  0.76
2009 Talbot JN, Skifter DA, Bianchi E, Monaghan DT, Toews ML, Murrin LC. Regulation of mu opioid receptor internalization by the scaffold protein RanBPM. Neuroscience Letters. 466: 154-8. PMID 19788913 DOI: 10.1016/J.Neulet.2009.09.048  0.76
2009 Costa BM, Feng B, Tsintsadze TS, Morley RM, Irvine MW, Tsintsadze V, Lozovaya NA, Jane DE, Monaghan DT. N-methyl-D-aspartate (NMDA) receptor NR2 subunit selectivity of a series of novel piperazine-2,3-dicarboxylate derivatives: preferential blockade of extrasynaptic NMDA receptors in the rat hippocampal CA3-CA1 synapse. The Journal of Pharmacology and Experimental Therapeutics. 331: 618-26. PMID 19684252 DOI: 10.1124/Jpet.109.156752  0.76
2008 Whitney NP, Peng H, Erdmann NB, Tian C, Monaghan DT, Zheng JC. Calcium-permeable AMPA receptors containing Q/R-unedited GluR2 direct human neural progenitor cell differentiation to neurons. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 2888-900. PMID 18403631 DOI: 10.1096/Fj.07-104661  0.76
2008 Brothwell SL, Barber JL, Monaghan DT, Jane DE, Gibb AJ, Jones S. NR2B- and NR2D-containing synaptic NMDA receptors in developing rat substantia nigra pars compacta dopaminergic neurones. The Journal of Physiology. 586: 739-50. PMID 18033813 DOI: 10.1113/Jphysiol.2007.144618  0.76
2006 Bean L, Zheng H, Patel KP, Monaghan DT. Regional variations in NMDA receptor downregulation in streptozotocin-diabetic rat brain. Brain Research. 1115: 217-22. PMID 16938282 DOI: 10.1016/J.Brainres.2006.07.090  0.76
2006 Maurice T, Meunier J, Feng B, Ieni J, Monaghan DT. Interaction with sigma(1) protein, but not N-methyl-D-aspartate receptor, is involved in the pharmacological activity of donepezil. The Journal of Pharmacology and Experimental Therapeutics. 317: 606-14. PMID 16397090 DOI: 10.1124/Jpet.105.097394  0.76
2005 Morley RM, Tse HW, Feng B, Miller JC, Monaghan DT, Jane DE. Synthesis and pharmacology of N1-substituted piperazine-2,3-dicarboxylic acid derivatives acting as NMDA receptor antagonists. Journal of Medicinal Chemistry. 48: 2627-37. PMID 15801853 DOI: 10.1021/Jm0492498  0.76
2005 Kinarsky L, Feng B, Skifter DA, Morley RM, Sherman S, Jane DE, Monaghan DT. Identification of subunit- and antagonist-specific amino acid residues in the N-Methyl-D-aspartate receptor glutamate-binding pocket. The Journal of Pharmacology and Experimental Therapeutics. 313: 1066-74. PMID 15743930 DOI: 10.1124/Jpet.104.082990  0.76
2005 Feng B, Morley RM, Jane DE, Monaghan DT. The effect of competitive antagonist chain length on NMDA receptor subunit selectivity. Neuropharmacology. 48: 354-9. PMID 15721167 DOI: 10.1016/J.Neuropharm.2004.11.004  0.76
2005 Shimoyama N, Shimoyama M, Davis AM, Monaghan DT, Inturrisi CE. An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance. The Journal of Pharmacology and Experimental Therapeutics. 312: 834-40. PMID 15388787 DOI: 10.1124/Jpet.104.074856  0.76
2005 Monaghan DT, More JCA, Feng B, Jane DE. Glutamate receptors ionotropic Dopamine and Glutamate in Psychiatric Disorders. 79-116. DOI: 10.1007/978-1-59259-852-6_4  0.76
2004 Lozovaya NA, Grebenyuk SE, Tsintsadze TSh, Feng B, Monaghan DT, Krishtal OA. Extrasynaptic NR2B and NR2D subunits of NMDA receptors shape 'superslow' afterburst EPSC in rat hippocampus. The Journal of Physiology. 558: 451-63. PMID 15146049 DOI: 10.1113/Jphysiol.2004.063792  0.76
2004 Feng B, Tse HW, Skifter DA, Morley R, Jane DE, Monaghan DT. Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid. British Journal of Pharmacology. 141: 508-16. PMID 14718249 DOI: 10.1038/Sj.Bjp.0705644  0.76
2003 Xiong H, McCabe L, Skifter D, Monaghan DT, Gendelman HE. Activation of NR1a/NR2B receptors by monocyte-derived macrophage secretory products: implications for human immunodeficiency virus type one-associated dementia. Neuroscience Letters. 341: 246-50. PMID 12697294 DOI: 10.1016/S0304-3940(03)00194-0  0.76
2000 Hrabetova S, Serrano P, Blace N, Tse HW, Skifter DA, Jane DE, Monaghan DT, Sacktor TC. Distinct NMDA receptor subpopulations contribute to long-term potentiation and long-term depression induction. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: RC81. PMID 10827202 DOI: 10.1523/Jneurosci.20-12-J0002.2000  0.76
2000 Glover RT, Angiolieri M, Kelly S, Monaghan DT, Wang JY, Smithgall TE, Buller AL. Interaction of the N-methyl-D-aspartic acid receptor NR2D subunit with the c-Abl tyrosine kinase. The Journal of Biological Chemistry. 275: 12725-9. PMID 10777567 DOI: 10.1074/Jbc.275.17.12725  0.76
2000 Christie JM, Jane DE, Monaghan DT. Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites. The Journal of Pharmacology and Experimental Therapeutics. 292: 1169-74. PMID 10688637  0.76
1999 Rosenquist TH, Schneider AM, Monogham DT. N-methyl-D-aspartate receptor agonists modulate homocysteine-induced developmental abnormalities. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 13: 1523-31. PMID 10463943 DOI: 10.1096/Fasebj.13.12.1523  0.76
1999 Christie JM, Wenthold RJ, Monaghan DT. Insulin causes a transient tyrosine phosphorylation of NR2A and NR2B NMDA receptor subunits in rat hippocampus. Journal of Neurochemistry. 72: 1523-8. PMID 10098857 DOI: 10.1046/J.1471-4159.1999.721523.X  0.76
1998 Monaghan DT, Andaloro VJ, Skifter DA. Molecular determinants of NMDA receptor pharmacological diversity. Progress in Brain Research. 116: 171-90. PMID 9932377 DOI: 10.1016/S0079-6123(08)60437-9  0.76
1998 Brown JC, Rosenquist TH, Monaghan DT. ERK2 activation by homocysteine in vascular smooth muscle cells. Biochemical and Biophysical Research Communications. 251: 669-76. PMID 9790967 DOI: 10.1006/Bbrc.1998.9535  0.76
1998 Thomas MP, Monaghan DT, Morrisett RA. Evidence for a causative role of N-methyl-D-aspartate receptors in an in vitro model of alcohol withdrawal hyperexcitability. The Journal of Pharmacology and Experimental Therapeutics. 287: 87-97. PMID 9765326  0.76
1998 Brown JC, Tse HW, Skifter DA, Christie JM, Andaloro VJ, Kemp MC, Watkins JC, Jane DE, Monaghan DT. [3H]homoquinolinate binds to a subpopulation of NMDA receptors and to a novel binding site. Journal of Neurochemistry. 71: 1464-70. PMID 9751179 DOI: 10.1046/J.1471-4159.1998.71041464.X  0.76
1998 Thomas MP, Webster WW, Norgren RB, Monaghan DT, Morrisett RA. Survival and functional demonstration of interregional pathways in fore/midbrain slice explant cultures. Neuroscience. 85: 615-26. PMID 9622257 DOI: 10.1016/S0306-4522(97)00646-5  0.76
1998 Thomas MP, Davis MI, Monaghan DT, Morrisett RA. Organotypic brain slice cultures for functional analysis of alcohol-related disorders: novel versus conventional preparations. Alcoholism, Clinical and Experimental Research. 22: 51-9. PMID 9514285 DOI: 10.1111/J.1530-0277.1998.Tb03616.X  0.76
1998 Andaloro VJ, Monaghan DT, Rosenquist TH. Dextromethorphan and other N-methyl-D-aspartate receptor antagonists are teratogenic in the avian embryo model Pediatric Research. 43: 1-7. PMID 9432105 DOI: 10.1203/00006450-199801000-00001  0.76
1997 Willis CL, Dauenhauer DL, Humphrey JM, Chamberlin AR, Buller AL, Monaghan DT, Bridges RJ. Methylation of the NMDA receptor agonist L-trans-2,3-pyrrolidine-dicarboxylate: enhanced excitotoxic potency and selectivity. Toxicology and Applied Pharmacology. 144: 45-55. PMID 9169068 DOI: 10.1006/Taap.1997.8112  0.76
1997 Buller AL, Monaghan DT. Pharmacological heterogeneity of NMDA receptors: Characterization of NR1a/NR2D heteromers expressed in Xenopus oocytes European Journal of Pharmacology. 320: 87-94. PMID 9049607 DOI: 10.1016/S0014-2999(96)00880-1  0.76
1997 Monaghan DT, Larsen H. NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology Journal of Pharmacology and Experimental Therapeutics. 280: 614-620. PMID 9023271  0.76
1995 Liu L, Brown JC, Webster WW, Morrisett RA, Monaghan DT. Insulin potentiates N-methyl-D-aspartate receptor activity in Xenopus oocytes and rat hippocampus. Neuroscience Letters. 192: 5-8. PMID 7675309 DOI: 10.1016/0304-3940(95)11593-L  0.76
1995 Buller AL, Larson HC, Morrisett RA, Monaghan DT. Glycine modulates ethanol inhibition of heteromeric N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Molecular Pharmacology. 48: 717-23. PMID 7476899  0.76
1994 Buller AL, Larson HC, Schneider BE, Beaton JA, Morrisett RA, Monaghan DT. The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 5471-84. PMID 7916045 DOI: 10.1523/Jneurosci.14-09-05471.1994  0.76
1992 Beaton JA, Stemsrud K, Monaghan DT. Identification of a novel N-methyl-D-aspartate receptor population in the rat medial thalamus Journal of Neurochemistry. 59: 754-757. PMID 1385829  0.76
1992 Monaghan DT, Beaton JA. Pharmacologically-distinct NMDA receptor populations of the cerebellum, medial thalamic nuclei and forebrain Molecular Neuropharmacology. 2: 71-75.  0.76
1991 Monaghan DT, Beaton JA. Quinolinate differentiates between forebrain and cerebellar NMDA receptors European Journal of Pharmacology. 194: 123-125. PMID 1676371 DOI: 10.1016/0014-2999(91)90134-C  0.76
1991 Monaghan DT. Differential stimulation of [3H]MK-801 binding to subpopulations of NMDA receptors Neuroscience Letters. 122: 21-24. PMID 1676144 DOI: 10.1016/0304-3940(91)90183-T  0.76
1990 Ułas J, Monaghan DT, Cotman CW. Kainate receptors in the rat hippocampus: A distribution and time course of changes in response to unilateral lesions of the entorhinal cortex Journal of Neuroscience. 10: 2352-2362. PMID 2165522 DOI: 10.1523/Jneurosci.10-07-02352.1990  0.76
1990 Ułas J, Monaghan DT, Cotman CW. Plastic response of hippocampal excitatory amino acid receptors to deafferentation and reinnervation Neuroscience. 34: 9-17. PMID 2158009 DOI: 10.1016/0306-4522(90)90300-S  0.76
1990 Anderson KJ, Monaghan DT, Bridges RJ, Tavoularis AL, Cotman CW. Autoradiographic characterization of putative excitatory amino acid transport sites Neuroscience. 38: 311-322. PMID 1979852 DOI: 10.1016/0306-4522(90)90030-8  0.76
1990 Watson GB, Monaghan DT, Lanthorn TH. Selective activation of oscillatory currents by trans-ACPD in rat brain mRNA-injected Xenopus oocytes and their blockade by NMDA. European Journal of Pharmacology. 179: 479-81. PMID 1694771 DOI: 10.1016/0014-2999(90)90194-B  0.76
1989 Cotman CW, Geddes JW, Bridges RJ, Monaghan DT. N-methyl-D-aspartate receptors and Alzheimer's disease Neurobiology of Aging. 10: 603-605. PMID 2572983 DOI: 10.1016/0197-4580(89)90144-9  0.76
1989 Palmer E, Monaghan DT, Cotman CW. Trans-ACPD, a selective agonist of the phosphoinositide-coupled excitatory amino acid receptor European Journal of Pharmacology. 166: 585-587. PMID 2553440 DOI: 10.1016/0014-2999(89)90383-X  0.76
1989 Monaghan DT, Bridges RJ, Cotman CW. The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system Annual Review of Pharmacology and Toxicology. 29: 365-402. PMID 2543272 DOI: 10.1146/Annurev.Pa.29.040189.002053  0.76
1989 Westerberg E, Monaghan DT, Kalimo H, Cotman CW, Wieloch TW. Dynamic changes of excitatory amino acid receptors in the rat hippocampus following transient cerebral ischemia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 9: 798-805. PMID 2538582 DOI: 10.1523/Jneurosci.09-03-00798.1989  0.76
1989 Cotman CW, Monaghan DT, Geddes JW. N‐methyl‐D‐aspartate receptors, synaptic plasticity, and Alzheimer's disease Drug Development Research. 17: 331-338. DOI: 10.1002/ddr.430170408  0.76
1988 Palmer E, Monaghan DT, Cotman CW. Glutamate receptors and phosphoinositide metabolism: stimulation via quisqualate receptors is inhibited by N-methyl-D-aspartate receptor activation Brain Research. 464: 161-165. PMID 2905924 DOI: 10.1016/0169-328X(88)90008-3  0.76
1988 Monaghan DT, Olverman HJ, Nguyen L, Watkins JC, Cotman CW. Two classes of N-methyl-D-aspartate recognition sites: differential distribution and differential regulation by glycine. Proceedings of the National Academy of Sciences of the United States of America. 85: 9836-40. PMID 2904680 DOI: 10.1073/Pnas.85.24.9836  0.76
1988 Bridges RJ, Kadri MM, Monaghan DT, Nunn PB, Watkins JC, Cotman CW. Inhibition of [3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding by the excitotoxin beta-N-oxalyl-L-alpha,beta-diaminopropionic acid. European Journal of Pharmacology. 145: 357-9. PMID 2895006 DOI: 10.1016/0014-2999(88)90442-6  0.76
1988 Cotman CW, Monaghan DT, Ganong AH. Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity Annual Review of Neuroscience. 11: 61-80. PMID 2452598 DOI: 10.1146/Annurev.Ne.11.030188.000425  0.76
1987 Monaghan DT, Geddes JW, Yao D, Chung C, Cotman CW. [3H]TCP binding sites in Alzheimer's disease Neuroscience Letters. 73: 197-200. PMID 3029638 DOI: 10.1016/0304-3940(87)90017-6  0.76
1987 Westerberg E, Monaghan DT, Cotman CW, Wieloch T. Excitatory amino acid receptors and ischemic brain damage in the rat Neuroscience Letters. 73: 119-124. PMID 2881232 DOI: 10.1016/0304-3940(87)90004-8  0.76
1987 Cotman CW, Monaghan DT, Ottersen OP, Storm-Mathisen J. Anatomical organization of excitatory amino acid receptors and their pathways Trends in Neurosciences. 10: 273-280. DOI: 10.1016/0166-2236(87)90172-X  0.76
1986 Monaghan DT, Nguyen L, Cotman CW. The distribution of [3H]kainate binding sites in primate hippocampus is similar to the distribution of both Ca2+-sensitive and Ca2+-insensitive [3H]kainate binding sites in rat hippocampus Neurochemical Research. 11: 1073-1082. PMID 3748275 DOI: 10.1007/BF00965595  0.76
1986 Anderson KJ, Monaghan DT, Cangro CB, Namboodiri MAA, Neale JH, Cotman CW. Localization of N-acetylaspartylglutamate-like immunoreactivity in selected areas of the rat brain Neuroscience Letters. 72: 14-20. PMID 3543748 DOI: 10.1016/0304-3940(86)90610-5  0.76
1986 Olverman HJ, Monaghan DT, Cotman CW, Watkins JC. [3H]CPP, a new competitive ligand for NMDA receptors. European Journal of Pharmacology. 131: 161-2. PMID 3028828 DOI: 10.1016/0014-2999(86)90533-9  0.76
1986 Cotman CW, Monaghan DT. Anatomical organization of excitatory amino acid receptors and their properties Advances in Experimental Medicine and Biology. 203: 237-252. PMID 3024456 DOI: 10.1007/978-1-4684-7971-3_18  0.76
1986 Monaghan DT, Cotman CW. Identification and properties of N-methyl-D-aspartate receptors in rat brain synaptic plasma membranes Proceedings of the National Academy of Sciences of the United States of America. 83: 7532-7536. PMID 3020547 DOI: 10.1073/Pnas.83.19.7532  0.76
1986 Bridges RJ, Hearn TJ, Monaghan DT, Cotman CW. A comparison of 2-amino-4-phosphonobutyric acid (AP4) receptors and [3H]AP4 binding sites in the rat brain Brain Research. 375: 204-209. PMID 3013370 DOI: 10.1016/0006-8993(86)90977-7  0.76
1986 Harris EW, Ganong AH, Monaghan DT, Watkins JC, Cotman CW. Action of 3-((+/-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP): a new and highly potent antagonist of N-methyl-D-aspartate receptors in the hippocampus. Brain Research. 382: 174-7. PMID 2876750 DOI: 10.1016/0006-8993(86)90128-9  0.76
1985 Geddes JW, Monaghan DT, Cotman CW, Lott IT, Kim RC, Chui HC. Plasticity of hippocampal circuitry in Alzheimer's disease. Science (New York, N.Y.). 230: 1179-81. PMID 4071042 DOI: 10.1126/Science.4071042  0.76
1985 Altschuler RA, Monaghan DT, Haser WG, Wenthold RJ, Curthoys NP, Cotman CW. Immunocytochemical localization of glutaminase-like and aspartate aminotransferase-like immunoreactivities in the rat and guinea pig hippocampus. Brain Research. 330: 225-33. PMID 3886076 DOI: 10.1016/0006-8993(85)90681-X  0.76
1985 Mena EE, Monaghan DT, Whittemore SR, Cotman CW. Cations differentially affect subpopulations of l-glutamate receptors in rat synaptic plasma membranes Brain Research. 329: 319-322. PMID 2983842 DOI: 10.1016/0006-8993(85)90542-6  0.76
1985 Monaghan DT, Cotman CW. Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain Journal of Neuroscience. 5: 2909-2919. PMID 2865341  0.76
1985 Monaghan DT, Yao D, Cotman CW. l-[3H]Glutamate binds to kainate-, NMDA- and AMPA-sensitive binding sites: an autoradiographic analysis Brain Research. 340: 378-383. PMID 2862960 DOI: 10.1016/0006-8993(85)90936-9  0.76
1984 Monaghan DT, Yao D, Olverman HJ, Watkins JC, Cotman CW. Autoradiography of D-2-[3H]amino-5-phosphonopentanoate binding sites in rat brain. Neuroscience Letters. 52: 253-8. PMID 6151632 DOI: 10.1016/0304-3940(84)90170-8  0.76
1984 Mena EE, Whittemore SR, Monaghan DT, Cotman CW. Ionic regulation of glutamate binding sites Life Sciences. 35: 2427-2433. PMID 6151108 DOI: 10.1016/0024-3205(84)90451-X  0.76
1984 Monaghan DT, Yao D, Cotman CW. Distribution of [3H]AMPA binding sites in rat brain as determined by quantitative autoradiography Brain Research. 324: 160-164. PMID 6097340 DOI: 10.1016/0006-8993(84)90636-X  0.76
1983 Monaghan DT, McMills MC, Chamberlin AR, Cotman CW. Synthesis of [3H]2-amino-4-phosphonobutyric acid and characterization of its binding to rat brain membranes: a selective ligand for the chloride/calcium-dependent class of L-glutamate binding sites. Brain Research. 278: 137-44. PMID 6640305 DOI: 10.1016/0006-8993(83)90232-9  0.76
1983 Monaghan DT, Holets VR, Toy DW, Cotman CW. Anatomical distributions of four pharmacologically distinct 3H-L-glutamate binding sites Nature. 306: 176-179. PMID 6316143 DOI: 10.1038/306176a0  0.76
1983 Whittemore SR, Edward Mena E, Monaghan DT, Cotman CW. Regional distribution and ionic requirement of Cl-/Ca2+-activated and Cl-/Ca2+-independent glutamate receptors in rat brain Brain Research. 277: 99-107. PMID 6315142 DOI: 10.1016/0006-8993(83)90911-3  0.76
1983 Fagg GE, Edward Mena E, Monaghan DT, Cotman CW. Freezing eliminates a specific population of l-glutamate receptors in synaptic membranes Neuroscience Letters. 38: 157-162. PMID 6312382 DOI: 10.1016/0304-3940(83)90033-2  0.76
1982 Monaghan DT, Edward Mena E, Cotman CW. The effect of entorhinal cortical ablation on the distribution of muscarinic cholinergic receptors in the rat hippocampus Brain Research. 234: 480-485. PMID 7059841 DOI: 10.1016/0006-8993(82)90891-5  0.76
1982 Monaghan DT, Cotman CW. The distribution of [3H]kainic acid binding sites in rat CNS as determined by autoradiography Brain Research. 252: 91-100. PMID 6293660 DOI: 10.1016/0006-8993(82)90981-7  0.76
1981 Mena EE, Monaghan DT, Cotman CW. Lesion-induced alterations of lectin binding sites in the rat dentate gyrus Neuroscience. 6: 1975-1983. PMID 7301114 DOI: 10.1016/0306-4522(81)90037-3  0.76
1981 Foster AC, Mena EE, Monaghan DT, Cotman CW. Synaptic localization of kainic acid binding sites Nature. 289: 73-75. PMID 6256647 DOI: 10.1038/289073a0  0.76
Show low-probability matches.